IVI and the World Health Organization

 

On 12 May 1997, the Fiftieth World Health Assembly (WHA50) voted to approve the Establishment of the IVI, becoming a founding member of the Institute.

WHA50 Deliberations on joining IVI

 

WHA50, Resolution 12

 

WHO Leadership at IVI

 

The IVI Constitution provides the WHO a permanent seat on the IVI Board of Trustees.

 

IVI: Partner on WHO Committees and Initiatives

 

IVI scientists and researchers play key roles across the WHO ecosystem, codeveloping solutions on vaccine delivery, treatment costs, and vaccine safety. The development of IVI’s Oral Cholera Vaccine enabled the WHO to establish the ICG-administered cholera vaccine stockpile and the Ending Cholera—A Global Roadmap to 2030 strategy. IVI is a member of the following WHO initiatives:

 

Coalition of Interested Parties (CIP) Network for Regulatory Systems Strengthening (RSS)

Global Clinical Trials Forum (GCTF)

Global Task Force on Cholera Control (GTFCC)

Global Vaccine Safety Initiative (GVSI)

Implementation Research Advisory Committee (IVIR-AC)

Initiative for Vaccine Research (IVR)

Interim Medical Countermeasures Network (i-MCM-Net)

International Coordinating Group on vaccine provision for Cholera (ICG)

Product Development for Vaccine Advisory Committee (PDVAC)